🇲🇺 Country Profile

Mauritius

Indian pharmaceuticals serving Mauritius

🇲🇺 $58.0M
All data from DGCIS India export records (fiscal year, April–March).
$58.0M
Scale
Mauritius' patients receive $58.0M in Indian pharmaceutical products annually, almost entirely finished medicines ready for dispensing.
94%
Medicine
Overwhelmingly finished medicines, drug formulations account for 94% of shipments.
1.6×
Trajectory
India's pharmaceutical supply to Mauritius has grown 1.6× over the past decade, strong, sustained expansion.
Context
Part of India's pharmaceutical supply network across Africa.
Impact
Indian pharmaceutical companies have both exported to and invested directly in Mauritius, building trade and operational presence.
Export Trend DGCIS FY
Pharmaceutical Composition Trend DGCIS CY 2014–2025

All pharmaceutical categories from DGCIS

Category Mix, FY 2025–26 DGCIS
Medicines $54.6M (93.6%) Surgical & Hospital Supplies $2.1M (3.6%) Traditional & Herbal $1.4M (2.4%) Vaccines $0.11M (0.2%) Medicine Ingredients $0.10M (0.2%)
Top Products, FY 2025–26 DGCIS
Indian Pharma Investment in Mauritius Source: RBI ODI Data

Total RBI-approved ODI commitments by Indian pharmaceutical companies into Mauritius: $504M across 101 filings (2011-2025).